Glucagon

Active ingredient: Glucagon

In short: Glucagon for Injection is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus. Glucagon for Injection is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult p

Forms & strengthsGlucagon for Injection is a white to off white lyophilized powder supplied as follows: Single-dose vial containing 1 mg Glucagon for Injection with a pre-filled syringe containing 1 mL of diluent fo Glucagon.
LabelAmphastar Pharmaceuticals, Inc.
Label updatedAug 13, 2026

What is Glucagon used for?

Glucagon for Injection is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus.

Glucagon for Injection is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients.

Glucagon dosage

Glucagon for Injection is for subcutaneous, intramuscular, or intravenous injection. Administer intravenously ONLY under medical supervision.Instruct patients and their caregivers on the signs and symptoms of severe hypoglycemia. Because severe hypoglycemia requires the help of others to recover, instruct the patient to inform those around them about Glucagon for Injection and its Instructions for Use. Administer Glucagon for Injection as soon as possible when severe hypoglycemia is recognized.Instruct the patient or caregiver to read the Instructions for Use at the time they receive a prescription for Glucagon for Injection. Emphasize the following instructions to the patient or caregiver:

Using the supplied prefilled syringe, carefully insert the needle through the rubber stopper of the vial containing Glucagon for Injection powder and inject all the liquid from the syringe into the vial.

Swirl the vial gently until the powder is completely dissolved and no particles remain in the fluid. The reconstituted solution should be clear and of a water-like consistency at time of use. Inspect visually for particulate matter and discoloration. If the resulting solution is cloudy or contains particulate matter do not use.

The reconstituted solution is 1 mg per mL glucagon. Use immediately after reconstitution.

Immediately after reconstitution, use the same syringe to withdraw the correct dose of Glucagon for Injection.

Inject the solution subcutaneously or intramuscularly in the upper arm, thigh, or buttocks. In addition, healthcare providers may administer intravenously.

Call for emergency assistance immediately after administering the dose.

If there has been no response after 15 minutes, an additional dose of Glucagon for Injection may be administered while waiting for emergency assistance.

When the patient has responded to the treatment and is able to swallow, give oral carbohydrates to restore the liver glycogen and prevent recurrence of hypoglycemia.

Discard any unused portion.

Adults and Pediatric Patients Weighing 20 kg or More

The recommended dosage is 1 mg (1 mL) injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks. Alternatively, healthcare providers may administer the dose intravenously.

If there has been no response after 15 minutes, an additional 1 mg dose (1 mL) of Glucagon for Injection may be administered while waiting for emergency assistance.

Pediatric Patients Weighing Less Than 20 kg

The recommended dosage is 0.5 mg (0.5 mL) or dose equivalent to 20 to 30 mcg/kg injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks. Alternatively, healthcare providers may administer the dose intravenously. …

How to take Glucagon — instructions & advice from the label

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Recognition of Severe Hypoglycemia

Inform patient and family members or caregivers on how to recognize the signs and symptoms of severe hypoglycemia and the risks of prolonged hypoglycemia.

Administration

Review the Patient Information and Instructions for Use with the patient and family members or caregivers.

Serious Hypersensitivity

Inform patients that allergic reactions can occur with Glucagon for Injection. Advise patients to seek immediate medical attention if they experience any symptoms of serious hypersensitivity reactions .

Warnings & precautions

Do not take this medicine if: Glucagon for Injection is contraindicated in patients with:

Pheochromocytoma because of the risk of substantial increase in blood pressure

Insulinoma because of the risk of hypoglycemia

Known hypersensitivity to glucagon or any of the excipients in Glucagon for Injection. Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension

Glucagonoma when used as a diagnostic aid because of the risk of hypoglycemia

Glucagon for Injection is contraindicated in patients with pheochromocytoma because glucagon may stimulate the release of catecholamines from the tumor . If the patient develops a substantial increase in blood pressure and a previously undiagnosed pheochromocytoma is suspected, 5 to 10 mg of phentolamine mesylate, administered intravenously, has been shown to be effective in lowering blood pressure.

In patients with insulinoma, administration of glucagon may produce an initial increase in blood glucose; however, Glucagon for Injection administration may directly or indirectly (through an initial rise in blood glucose) stimulate exaggerated insulin release from an insulinoma and cause hypoglycemia. Glucagon for Injection is contraindicated in patients with insulinoma . If a patient develops symptoms of hypoglycemia after a dose of Glucagon for Injection, give glucose orally or intravenously.

Allergic reactions have been reported with glucagon, these include generalized rash, and in some cases anaphylactic shock with breathing difficulties and hypotension. Glucagon for Injection is contraindicated in patients with a prior hypersensitivity reaction .

Glucagon for Injection is effective in treating hypoglycemia only if sufficient hepatic glycogen is present. …

Glucagon side effects

The following important adverse reactions are described below and elsewhere in the labeling:

Hypersensitivity and Allergic Reactions

Necrolytic Migratory Erythema

Hyperglycemia in Patients with Diabetes Mellitus when Used as a Diagnostic Aid

Blood Pressure and Heart Rate Increase in Patients with Cardiac Disease when used as a Diagnostic Aid

The following adverse reactions have been identified during post-approval use of glucagon. Because these reactions are reported voluntarily from a population of uncertain size, it is generally not possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Injection site reactions including erythema and swelling

Nausea

Vomiting

Headache

Dizziness

Asthenia

Pallor

Diarrhea

Somnolence

Generalized allergic reactions including anaphylactic shock with breathing difficulties and hypotension

Hypertension and tachycardia

Decreased blood pressure. Hypotension has been reported up to 2 hours after administration in patients receiving glucagon as premedication for upper gastrointestinal endoscopy procedures.

Hypoglycemia and hypoglycemic coma. Patients taking indomethacin may be more likely to experience hypoglycemia following glucagon administration .

Necrolytic Migratory Erythema (NME) cases have been reported post marketing in patients receiving continuous infusion of glucagon.

Drug interactions

Table 1: Clinically Significant Drug Interactions with Glucagon for Injection

Beta Blockers

Clinical Impact: | Patients taking beta-blockers may have a transient increase in pulse and blood pressure when given Glucagon for Injection.

Intervention: | The increase in blood pressure and heart rate may require therapy in patients with coronary artery disease.

Indomethacin

Clinical Impact: | In patients taking indomethacin, Glucagon for Injection may lose its ability to raise blood glucose or may even produce hypoglycemia.

Intervention: | Monitor blood glucose levels during glucagon treatment of patients taking indomethacin.

Anticholinergic Drugs

Clinical Impact: | The concomitant use of anticholinergic drugs and Glucagon for Injection increase the risk of gastrointestinal adverse reactions due to additive effects on inhibition of gastrointestinal motility.

Intervention: | Concomitant use of anticholinergic drugs with Glucagon for Injection for use as a diagnostic aid is not recommended.

Warfarin

Clinical Impact: | Glucagon for Injection may increase the anticoagulant effect of warfarin.

Intervention: | Monitor patients for unusual bruising or bleeding, as adjustments in warfarin dosage may be required.

Insulin

Clinical Impact: | Insulin acts antagonistically to glucagon. …

About this medicine

Glucagon is an antihypoglycemic agent and a gastrointestinal motility inhibitor. Glucagon is produced by solid state peptide synthesis and is highly purified. The chemical structure of the glucagon is identical to human glucagon. Glucagon is a single-chain polypeptide that contains 29 amino acid residues and has a molecular weight of 3483 Daltons.The empirical formula is C153H225N43O49S. The primary sequence of glucagon is shown below.

Crystalline glucagon (synthetic origin) is a white to off-white powder. It is relatively insoluble in water but is soluble at a pH of less than 3 or more than 9.5.

Glucagon for Injection is a sterile lyophilized white to off white powder in a vial and a syringe of sterile diluent for intravenous, intramuscular, or subcutaneous use. The vial contains 1 mg of glucagon, 49 mg of lactose monohydrate. Hydrochloric acid may have been added during manufacture to adjust the pH of the glucagon to 2.5 to 3.0. One International Unit of glucagon is equivalent to 1 mg of glucagon. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 8cc40354-b5ac-45b6-a211-93b44444f2a3. Read the full official label on DailyMed.

Related medicines

Atorvastatin Metformin Losartan Semaglutide Insulin Glargine Empagliflozin Glipizide Insulin Lispro